PBA launches campaign and resource for women’s vision

Article

“See Jane See” allows you to provide more information, such as downloadable tip sheets, to your female patients.

Chicago- Prevent Blindness America (PBA) launched “See Jane See-Women’s Healthy Eyes Now,” a Web-based educational campaign dedicated solely to women’s vision health. “See Jane See” and the dedicated Web site, SeeJaneSee.org, offers free information and downloadable tip sheets created specifically for women across the age spectrum. Information will include symptoms, causes and treatment options for a variety of conditions.

According to the 2012 “Vision Problems in the US” study, http://www.visionproblemsus.org/index.html 66 percent of those experiencing blindness are women, 61 percent of those suffering with cataracts are women, and 65 percent of those with age-related macular degeneration are women. The causes for these conditions, including age, hormonal factors, and certain autoimmune diseases, are often very different for women than for men and the precautions and treatments may differ as well.

Downloadable “See Jane See” fact sheets include:

  • Pregnancy and Your Vision

  • Safe Use of Eye Cosmetics

  • Nutritional Supplements and Vision

  • Understanding Dry Eye
Recent Videos
Jennifer Li, MD, details a talk she gave alongside Melissa Barnett, OD, FAAO, FSLS, FBCLA, at CRU 2025 in Napa, California.
Deb Ristvedt, DO, details a handful of presentations on glaucoma she gave during CRU 2025 in Napa, California.
Cecelia Koetting, OD, FAAO, DipABO, weighs in on patient assessments, staining pattern insights, and diagnostic tips for patients who may have dry eye disease.
Melissa Barnett, OD, FAAO, FSLS, FBCLA, discusses keratoconus management, diagnosis, and other key insights at CRU 2025.
Cecelia Koetting, OD, FAAO, DipABO, details a talk she gave among optometrists and ophthalmologists at CRU 2025.
Alongside Rachelle Lin, OD, MS, FAAO; Nguyễn, MD, MSc, detailed what treatments are currently available for retinal vascular diseases, including neovascular age-related macular degeneration and diabetic retinopathy.
Dr Paul Karpecki discusses atropine formulation from Sydnexis following NDA acceptance by FDA
Ali Tafreshi sits down with Optometry Times to discuss Topcon's "Healthcare from the Eye" initiative.
Nora Lee Cothran, OD, FAAO, details a real-world study that found IOP-lowering benefits when switching patients with glaucoma to latanoprostene bunod treatment.
OptiLIFT in action: Dr. Julie McLaughlin's experience with the new device
© 2025 MJH Life Sciences

All rights reserved.